Last reviewed · How we verify
Dorzagliatin tablets
At a glance
| Generic name | Dorzagliatin tablets |
|---|---|
| Sponsor | Hua Medicine Limited |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Drug Interaction Study Between Dorzagliatin and Empagliflozin (PHASE1)
- A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes (PHASE4)
- Drug Interaction Study Between Dorzagliatin and Sitagliptin (PHASE1)
- A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers (PHASE1)
- Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes (PHASE2)
- A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers (PHASE1)
- A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |